- Advertisement -
Results of a recent systematic review and meta-analysis of cannabidiol’s (CBD’s) efficacy in reducing seizure frequency in patients with pharmacoresistant epilepsy were encouraging, but further research is needed.
Epilepsy affects an estimated 50 million people around the world. Beyond…
